Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
36 participants
OBSERVATIONAL
2021-06-09
2025-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Motor rECovery witH eArly imagiNg In STroke
NCT04165616
Muscle Coordination-Based Feedback for Stroke Rehabilitation
NCT06099444
Marker for Stroke Recovery
NCT05256368
Functional Connectivity In Relation To Proprioception and Sensorimotor Recovery in Stroke Patients (Feasibility Study)
NCT02445768
Direction Modulation of Muscle Synergies After a Stroke
NCT03063151
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy Age-matched controls
Healthy individuals ages 18-85
No interventions assigned to this group
Inpatients poststroke
Individuals post acute or subacute that that are inpatients at the Shirley Ryan AbilityLab ages 18-85
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ambulatory with or without an assistive device
* Ability to stand unassisted for at least 15 min
* Informed consent provided by participant
* English speaking
* Age 18-85 years old
* Unilateral, supratentorial ischemic or hemorrhagic stroke within the past six months
* Medical clearance from primary medical team (signed Medical Clearance form)
* Unassisted sitting balance at edge of mat or hospital bed ≥ 30 seconds
* Baseline Visible muscle contraction in hip flexors, knee extensors, and ankle dorsiflexors ( ≥1 MMT) or manual resistance against one muscle group (\>3 MMT)
* Adequate cognitive function as determined by the NIH scale: score ≤1 on question 1b and score =0 on question 1c
* Informed consent provided by participant or POA
* English speaking
Exclusion Criteria
* Lower extremity joint pain, contractures
* Major sensory deficits, or cardiovascular or respiratory symptoms contraindicative of walking
* History or evidence of orthopedic, muscular, or physical disability
* Taking current medications that may affect balance
* History or evidence of vestibular, auditory, or proprioceptive impairment
* History or indication of orthostatic hypotension
* History of any neurological disease
* Open wounds on surfaces in contact with HD-EMG electrodes
* Concurrent participation in other lower limb research studies that according to the PI is likely to affect study outcome or confound results
* Pregnancy
Patients:
* Severe aphasia limiting ability to express needs or discomfort verbally or nonverbally
* Severe behavioral neglect
* History of prior stroke
* Concurrent neurologic condition (i.e PD, TBI, MS, etc.)
* History of peripheral nerve injury
* Joint contracture or significant spasticity in the lower limbs (Modified Ashworth Scale ≥3)
* Severe knee, hip, or ankle osteoarthritis
* Severe osteoporosis as indicated by physician medical clearance
* Open wounds on surfaces in contact with HD-EMG electrodes
* Unstable spine or unhealed fractures
* Weight bearing precautions
* Unresolved deep vein thrombosis (DVT)
* Concurrent participation in other lower limb research studies that according to the PI is likely to affect study outcome or confound results
* Pregnancy
18 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shirley Ryan AbilityLab
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jose Pons
Principal Investigaor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jose L Pons, PhD
Role: PRINCIPAL_INVESTIGATOR
Shirley Ryan AbilityLab
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shirley Ryan AbilityLab
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STU00214290
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.